United States · FDA National Drug Code directory
Reyvow
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0002-4312_29f467c6-0365-4831-b4ce-9a0eefaf5896
- Product NDC
- 0002-4312
- Form
- TABLET
- Composition / generic term
- lasmiditan
- Labeler
- Eli Lilly and Company
- Marketing category
- NDA
- Marketing start / end (source format)
- 20191011 / 20280516
Source-listed ingredients
- LASMIDITAN — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BLISTER PACK in 1 CARTON (0002-4312-08) / 4 TABLET in 1 BLISTER PACK · 0002-4312-08
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →